http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63267721-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea37e5945b2086e8b53846f1f197218d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a59fb3cb1d285c13f187146a399bd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18a7d1606da2ec2ad08ae63822efb00e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
| filingDate | 1987-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3b4a69d74d43e71ffde0edf6d0e3d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07617ff963c5b22549f4ed791d34200 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c23733787f0d6b15163d9463c510e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_681f17df99e8d3e0117b1289042331f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68df1093947c9b3b69e1966947fd1638 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe24ad3a38bcdf9edb5377af4fd774f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0cefd74df3be749338cea4c975dc58 |
| publicationDate | 1988-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S63267721-A |
| titleOfInvention | Suppository of emorfazone |
| abstract | PURPOSE: To obtain an effective suppository free from mucosa irritation, by packing a uniform mixture comprising a ground blend of emorfazone and a cyclodextrin and fats and oils in an oily state at normal temperature as main components into soft capsules. n CONSTITUTION: A uniform mixture having 8,000W15,000 centipoise viscosity at normal temperature, comprising a ground blend of emorfazone shown by the formula, a nonacidic anti-inflammatory analgesic and a cyclodextrin (preferably a blend of 1mol. or the former and 0.1W1.0mol., especially 0.2W0.5mol. of the latter) and a oily base selected from pharmaceutically acceptable fats and oils in an oily state at normal temperature, preferably cotton seed oil or mixed acid group triglyceride of caprylic acid and caproic acid, as main components, is packed into soft capsules. By the use of the suppository, emorfazone can be administered to patients who can not be orally administered or to children. n COPYRIGHT: (C)1988,JPO&Japio |
| priorityDate | 1987-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.